Tissue-resident mast cells are derived from circulating committed progenitors, which are originated from pluripotent hematopoietic stem cells in bone marrow. These progenitors migrate into extravascular tissues, where they undergo diŠerentiation and maturation into tissue-speciˆc mast cell phenotypes. When activated by antigen or microenvironmental factors, mast cells release various biologically active products, including pre-formed mediators stored in secretory granules, de novo synthesized lipid mediators, and newly transcribed cytokines and chemokines, thereby promoting anaphylactic in‰ammation as well as other acute and chronic in‰ammatory diseases. Here, I will highlight the newest understanding of the phospholipase A 2 (PLA 2 )-driven lipid networks in the maturation and eŠector functions of mast cells and attendant allergic responses. Group III secreted PLA 2 , the sole mammalian homolog of the potent extrinsic anaphylaxis inducer bee venom PLA 2 , regulates mast cell maturation through the paracrine prostaglandin D 2 (PGD 2 ) circuit. While cytosolic PLA 2 a is essential for the generation of PGD 2 and leukotriene C 4 by mast cells, it is also functionally coupled, through the arachidonic acid transfer mechanism, with PGE 2 synthase in stromalˆbroblasts to provide anti-anaphylactic PGE 2 . In addition, the roles of two particular mast cell maturation-responsible genes, NDRG1 and NLRP3, in mast cells will be discussed. 
Interaction between mast cells andˆbroblasts are essential for proper mast cell maturation in tissues. sPLA2-III, an``anaphylactic sPLA2'' that is released from immature mast cells, is coupled withˆbroblastic L-PGDS to promote sustained production of microenvironmental PGD 2 , which in turn acts on DP1 on mast cells to facilitate mast cell maturation. Mature mast cells have more histamine granules and surface FceRI and express higher levels of cPLA 2 a and H-PGDS. Crosslinking of FceRI with multivalent antigen elicits explosive activation of mature mast cells, which leads to pro-allergic histamine release and thereby allergic reactions. On the other hand, cPLA 2 a/H-PGDS-driven immediate production of PGD 2 (via COX-1 and 2, which are omitted in theˆgure) by mature mast cells is anti-allergic. During mast cell maturation, PGE 2 , which exerts an anti-allergic eŠect via the PGE 2 receptor EP3, is produced byˆbroblasts in a manner dependent upon cPLA 2 a in mast cells, where cPLA 2 a-driven arachidonic acid is transferred to adjacentˆbroblasts through the transcellular route and then metabolized to PGE 2 by mPGES-1. 
